Alejandra Flores-Chávez

2.1k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

Alejandra Flores-Chávez is a scholar working on Rheumatology, Physiology and Oncology. According to data from OpenAlex, Alejandra Flores-Chávez has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 6 papers in Physiology and 5 papers in Oncology. Recurrent topics in Alejandra Flores-Chávez's work include Salivary Gland Disorders and Functions (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Alejandra Flores-Chávez is often cited by papers focused on Salivary Gland Disorders and Functions (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Alejandra Flores-Chávez collaborates with scholars based in Spain, Mexico and France. Alejandra Flores-Chávez's co-authors include Manuel Ramos‐Casals, Xavier Mariette, Olivier Lambotte, Munther A. Khamashta, María E. Suarez‐Almazor, Julie R. Brahmer, Aleix Prat, Margaret K. Callahan, Niamh M. Keegan and Pilar Brito‐Zerón and has published in prestigious journals such as Pharmacology & Therapeutics, Nature Reviews Disease Primers and BioMed Research International.

In The Last Decade

Alejandra Flores-Chávez

17 papers receiving 1.2k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune-related adverse events of checkpoint inhibitors

2020 931 citations Manuel Ramos‐Casals, Julie R. Brahmer et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alejandra Flores-Chávez Spain	9	730	403	230	157	117	18	1.2k
Anne Cairoli Switzerland	8	1.3k 1.7×	478 1.2×	366 1.6×	242 1.5×	118 1.0×	26	1.7k
Julie Delyon France	17	649 0.9×	301 0.7×	130 0.6×	273 1.7×	57 0.5×	59	985
Sheeja T. Pullarkat United States	13	508 0.7×	179 0.4×	122 0.5×	234 1.5×	86 0.7×	43	980
Masahiro Hirayama Japan	18	250 0.3×	393 1.0×	106 0.5×	216 1.4×	162 1.4×	122	1.2k
Hee Jeong South Korea	20	480 0.7×	200 0.5×	190 0.8×	415 2.6×	186 1.6×	72	1.3k
Shogo Kumagai Japan	15	450 0.6×	254 0.6×	389 1.7×	216 1.4×	64 0.5×	37	1.0k
Niamh M. Keegan United States	9	770 1.1×	334 0.8×	280 1.2×	164 1.0×	103 0.9×	28	1.1k
Jae Ho Han South Korea	28	509 0.7×	299 0.7×	383 1.7×	448 2.9×	402 3.4×	88	1.5k
Abdul Rafeh Naqash United States	18	1.3k 1.7×	278 0.7×	479 2.1×	224 1.4×	94 0.8×	103	1.5k
Ramesh Kumar Pandey United States	8	699 1.0×	374 0.9×	198 0.9×	210 1.3×	67 0.6×	19	1.1k

Countries citing papers authored by Alejandra Flores-Chávez

Since Specialization

Citations

This map shows the geographic impact of Alejandra Flores-Chávez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra Flores-Chávez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra Flores-Chávez more than expected).

Fields of papers citing papers by Alejandra Flores-Chávez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandra Flores-Chávez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra Flores-Chávez. The network helps show where Alejandra Flores-Chávez may publish in the future.

Co-authorship network of co-authors of Alejandra Flores-Chávez

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandra Flores-Chávez. A scholar is included among the top collaborators of Alejandra Flores-Chávez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandra Flores-Chávez. Alejandra Flores-Chávez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ramos‐Casals, Manuel, Alejandra Flores-Chávez, Pilar Brito‐Zerón, Olivier Lambotte, & Xavier Mariette. (2022). Immune-related adverse events of cancer immunotherapies targeting kinases. Pharmacology & Therapeutics. 237. 108250–108250. 6 indexed citations

Flores-Chávez, Alejandra, Pilar Brito‐Zerón, Soledad Retamozo, et al.. (2022). Using Autoantibodies to Diagnose Systemic Autoimmune Diseases Triggered by Immune Checkpoint Inhibitors: A Clinical Perspective. Critical Reviews in Immunology. 42(4). 21–36. 2 indexed citations

Brito‐Zerón, Pilar, Soledad Retamozo, Alejandra Flores-Chávez, et al.. (2022). Practical diagnostic tips for the Sjögren Clinic: pearls, myths and mistakes. Clinical and Experimental Rheumatology. 40(12). 2413–2427. 4 indexed citations

Sisó‐Almirall, Antoni, Pilar Brito‐Zerón, Alejandra Flores-Chávez, et al.. (2021). Practical guidelines for the early diagnosis of Sjögren's syndrome in primary healthcare.. PubMed. 39 Suppl 133(6). 197–205. 7 indexed citations

Retamozo, Soledad, Pilar Brito‐Zerón, Antoni Sisó‐Almirall, et al.. (2021). Haemophagocytic syndrome and COVID-19. Clinical Rheumatology. 40(4). 1233–1244. 55 indexed citations

Retamozo, Soledad, Antoni Sisó‐Almirall, Alejandra Flores-Chávez, Manuel Ramos‐Casals, & Pilar Brito‐Zerón. (2021). An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development. Expert Opinion on Pharmacotherapy. 22(17). 2359–2371. 10 indexed citations

Brito‐Zerón, Pilar, Antoni Sisó‐Almirall, Alejandra Flores-Chávez, Soledad Retamozo, & Manuel Ramos‐Casals. (2021). SARS-CoV-2 infection in patients with systemic autoimmune diseases. Clinical and Experimental Rheumatology. 39(3). 676–687. 19 indexed citations

Sisó‐Almirall, Antoni, Jiska Meijer, Pilar Brito‐Zerón, et al.. (2021). Practical guidelines for the early diagnosis of Sjögren's syndrome in primary healthcare. Clinical and Experimental Rheumatology. 39(6). 197–205. 12 indexed citations

Ramos‐Casals, Manuel, Julie R. Brahmer, Margaret K. Callahan, et al.. (2020). Immune-related adverse events of checkpoint inhibitors. Nature Reviews Disease Primers. 6(1). 38–38. 931 indexed citations breakdown →

10.

Retamozo, Soledad, Alejandra Flores-Chávez, Marta Consuegra‐Fernández, et al.. (2017). Cytokines as therapeutic targets in primary Sjögren syndrome. Pharmacology & Therapeutics. 184. 81–97. 22 indexed citations

11.

Pérez-de-Lis, M., Soledad Retamozo, Alejandra Flores-Chávez, et al.. (2017). Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry). Expert Opinion on Drug Safety. 16(11). 1255–1271. 96 indexed citations

12.

Flores-Chávez, Alejandra, J.A. Carrión, Xavier Forns, & Manuel Ramos‐Casals. (2017). Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection.. PubMed. 19(3). 87–97. 23 indexed citations

13.

Ruiz-Padilla, Alan Joel, Jorge Iván Gámez-Nava, Ana Míriam Saldaña-Cruz, et al.. (2016). The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis. BioMed Research International. 2016. 1–10. 7 indexed citations

14.

Flores-Chávez, Alejandra, et al.. (2016). Síndrome metabólico en mujeres derechohabientes del Instituto Mexicano del Seguro Social: prevalencia y factores asociados. 11(1). 3–9. 1 indexed citations

15.

Flores-Chávez, Alejandra, et al.. (2015). Interleucina-18 en síndrome metabólico. 10(3). 118–124. 1 indexed citations

16.

Flores-Chávez, Alejandra, et al.. (2015). Importancia de las infecciones en el lupus eritematoso sistémico. 10(1). 31–37.

17.

González-López, Laura, Alberto Daniel Rocha-Muñoz, Alejandra Flores-Chávez, et al.. (2014). Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis. Journal of Immunology Research. 2014. 1–10. 30 indexed citations

18.

Flores-Chávez, Alejandra, et al.. (2013). Las adipocinas como mediadoras en la inflamación y el sistema inmune. 8(3). 97–105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact